These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29541519)

  • 21. Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study.
    Molina CA; Montaner J; Abilleira S; Arenillas JF; Ribó M; Huertas R; Romero F; Alvarez-Sabín J
    Stroke; 2001 Dec; 32(12):2821-7. PubMed ID: 11739980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute stroke intervention: a systematic review.
    Prabhakaran S; Ruff I; Bernstein RA
    JAMA; 2015 Apr; 313(14):1451-62. PubMed ID: 25871671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis.
    Mullen MT; Pisapia JM; Tilwa S; Messé SR; Stein SC
    Stroke; 2012 Sep; 43(9):2350-5. PubMed ID: 22811451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
    Sekoranja L; Loulidi J; Yilmaz H; Lovblad K; Temperli P; Comelli M; Sztajzel RF
    Stroke; 2006 Jul; 37(7):1805-9. PubMed ID: 16763175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
    Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
    Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men.
    Arenillas JF; Sandoval P; Pérez de la Ossa N; Millán M; Guerrero C; Escudero D; Dorado L; López-Cancio E; Castillo J; Dávalos A
    Stroke; 2009 Feb; 40(2):344-9. PubMed ID: 19109538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyacrylic acid-coated nanoparticles loaded with recombinant tissue plasminogen activator for the treatment of mice with ischemic stroke.
    Huang L; Wang J; Huang S; Siaw-Debrah F; Nyanzu M; Zhuge Q
    Biochem Biophys Res Commun; 2019 Aug; 516(2):565-570. PubMed ID: 31235258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations.
    Seitz RJ; Hamzavi M; Junghans U; Ringleb PA; Schranz C; Siebler M
    Stroke; 2003 Aug; 34(8):1932-5. PubMed ID: 12829861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke.
    Nathaniel TI; Gainey J; Blum B; Montgomery C; Ervin L; Madeline L
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2524-2533. PubMed ID: 29859864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data.
    Trouillas P; Nighoghossian N; Getenet JC; Riche G; Neuschwander P; Froment JC; Turjman F; Jin JX; Malicier D; Fournier G; Gabry AL; Ledoux X; Derex L; Berthezène Y; Adeleine P; Xie J; Ffrench P; Dechavanne M
    Stroke; 1996 May; 27(5):882-90. PubMed ID: 8623108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limit of intraoperative near-infrared spectroscopy monitoring during endovascular thrombectomy in acute ischemic stroke.
    Hiramatsu R; Furuse M; Yagi R; Ohnishi H; Ikeda N; Nonoguchi N; Kawabata S; Miyachi S; Kuroiwa T
    Interv Neuroradiol; 2018 Feb; 24(1):57-63. PubMed ID: 29183174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Canine Model of Hemorrhagic Transformation Using Recombinant Tissue Plasminogen Activator Administration After Acute Ischemic Stroke.
    Jiang RH; Zu QQ; Xu XQ; Wang B; Ding Y; Wang J; Liu S; Shi HB
    Front Neurol; 2019; 10():673. PubMed ID: 31293509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
    Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
    J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous thrombolysis for acute ischemic stroke occurring during hospitalization for transient ischemic attack.
    Tsivgoulis G; Sharma VK; Mikulik R; Krogias C; Haršány M; Bavarsad Shahripour R; Athanasiadis D; Teoh HL; Piperidou C; Alexandrov AV
    Int J Stroke; 2014 Jun; 9(4):413-8. PubMed ID: 23981541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke.
    Alexandrov AV; Wojner AW; Grotta JC;
    J Neuroimaging; 2004 Apr; 14(2):108-12. PubMed ID: 15095554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bridging Therapy with i. v. rtPA in MCA Occlusion Prior to Endovascular Thrombectomy: a Double-Edged Sword?
    Kaesmacher J; Kleine JF
    Clin Neuroradiol; 2018 Mar; 28(1):81-89. PubMed ID: 27541957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
    Ringleb PA; Schellinger PD; Schranz C; Hacke W
    Stroke; 2002 May; 33(5):1437-41. PubMed ID: 11988629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis.
    Dong MX; Hu QC; Shen P; Pan JX; Wei YD; Liu YY; Ren YF; Liang ZH; Wang HY; Zhao LB; Xie P
    PLoS One; 2016; 11(7):e0158848. PubMed ID: 27387385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Komjathy SF; Poulton J; Stafford JL; Godard J
    Circulation; 1994 Jan; 89(1):361-5. PubMed ID: 8281671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.